Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (501-510 of 6,828) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|December 10, 2021
RNAi drugs at "a remarkable period of a renaissance"Asher Mullard
Nature Reviews. Drug Discovery|December 14, 2021
Antibody-oligonucleotide conjugates enter the clinicAsher Mullard
Nature Reviews. Drug Discovery|December 7, 2021
FDA approves first drug for common form of dwarfismAsher Mullard
Nature Reviews. Drug Discovery|November 19, 2021
Merck readies oral, macrocyclic PCSK9 inhibitor for phase II testAsher Mullard
Nature Reviews. Drug Discovery|October 6, 2023
MDMA-assisted therapy for PTSD passes phase III trialAsher Mullard
Nature Reviews. Drug Discovery|November 3, 2022
Second CTLA4-targeted checkpoint inhibitor secures FDA approvalAsher Mullard
Nature Reviews. Drug Discovery|October 10, 2022
Amylyx's ALS therapy secures FDA approval, as regulatory flexibility trumps underwhelming dataAsher Mullard
Nature Reviews. Drug Discovery|October 10, 2022
FDA approves first anti-IL-36 receptor antibody for rare skin diseaseAsher Mullard
Nature Reviews. Drug Discovery|January 14, 2022
Preclinical cancer research suffers another reproducibility blowAsher Mullard
Australian Family Physician|March 1, 1987
Homeopathy in medical practiceE Asher
Pageof 683

Showing results (501-510 of 6,828) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|December 10, 2021
RNAi drugs at "a remarkable period of a renaissance"Asher Mullard
Nature Reviews. Drug Discovery|December 14, 2021
Antibody-oligonucleotide conjugates enter the clinicAsher Mullard
Nature Reviews. Drug Discovery|December 7, 2021
FDA approves first drug for common form of dwarfismAsher Mullard
Nature Reviews. Drug Discovery|November 19, 2021
Merck readies oral, macrocyclic PCSK9 inhibitor for phase II testAsher Mullard
Nature Reviews. Drug Discovery|October 6, 2023
MDMA-assisted therapy for PTSD passes phase III trialAsher Mullard
Nature Reviews. Drug Discovery|November 3, 2022
Second CTLA4-targeted checkpoint inhibitor secures FDA approvalAsher Mullard
Nature Reviews. Drug Discovery|October 10, 2022
Amylyx's ALS therapy secures FDA approval, as regulatory flexibility trumps underwhelming dataAsher Mullard
Nature Reviews. Drug Discovery|October 10, 2022
FDA approves first anti-IL-36 receptor antibody for rare skin diseaseAsher Mullard
Nature Reviews. Drug Discovery|January 14, 2022
Preclinical cancer research suffers another reproducibility blowAsher Mullard
Australian Family Physician|March 1, 1987
Homeopathy in medical practiceE Asher
Pageof 683